Although DIZE is used for the treatment of trypanosomiasis or sleeping sickness, side effects may preclude its widespread clinical use [37–39] and specific compounds that selectively amplify ACE2 activity will be needed if this approach is to find utility. The gene discussed is ACE2; the disease is human African trypanosomiasis.